Disease: Epidermolysis bullosa dystrophica- dominant type
- [Translated article] Successful Control of Recalcitrant Pruritus in Epidermolysis Bullosa Pruriginosa With Dupilumab
- <em>COL7A1</em> Editing via RNA <em>Trans</em>-Splicing in RDEB-Derived Skin Equivalents
- A case of adult-onset localized recessive dystrophic epidermolysis bullosa, harboring the novel COL7A1 mutation p.G2754E and the previously reported mutation p.R1763
- A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab
- A case of dystrophic epidermolysis bullosa with a rare COL7A1 variant
- A case of intermediate recessive dystrophic epidermolysis bullosa with a novel COL7A1 mutation
- A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab
- A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A
- A rare cause of AA amyloidosis: Hereditary epidermolysis bullosa
- A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
- ABCB5(+) mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa
- ABCB5<sup>+</sup> mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa
- ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation
- Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma
- Analysis of COL7A1 pathogenic variants in a large cohort of dystrophic epidermolysis bullosa patients from Argentina reveals a new genotype-phenotype correlation
- Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa
- Availability of mRNA Obtained from Peripheral Blood Mononuclear Cells for Testing Mutation Consequences in Dystrophic Epidermolysis Bullosa
- Beremagene Geperpavec: First Approval
- Cas9-guided haplotyping of three truncation variants in autosomal recessive disease
- Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening
- Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita
- Characterisation of the pathophysiology of neuropathy and sensory dysfunction in a mouse model of recessive dystrophic epidermolysis bullosa
- Clinical and allelic heterogeneity in dystrophic epidermolysis bullosa- lessons from an Indian cohort
- Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa
- COL7A1 G2287R mutation with two clinical phenotypes in the same family: Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa
- Collagen VII maintains proteostasis in dermal fibroblasts by scaffolding TANGO1 cargo
- Creation and characterization of novel rat model for recessive dystrophic epidermolysis bullosa: Frameshift mutation of the Col7a1 gene leads to severe blistered phenotype
- Current Treatment Landscape for Dystrophic Epidermolysis Bullosa: From Surgical Management to Emerging Gene Therapies and Novel Skin Grafts
- Detection of revertant mosaicism in epidermolysis bullosa through Cas9-targeted long-read sequencing
- Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
- Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin
- Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa
- Dystrophic Epidermolysis Bullosa Inversa - Case Report and Review of the Literature
- Dystrophic epidermolysis bullosa: from disease biology to biologic therapy
- Elevated expression of interleukin-6 (IL-6) and serum amyloid A (SAA) in the skin and the serum of recessive dystrophic epidermolysis bullosa: Skin as a possible source of IL-6 through Toll-like receptor ligands and SAA
- Epidermal or Dermal Collagen VII Is Sufficient for Skin Integrity: Insights to Anchoring Fibril Homeostasis
- Epidermolysis bullosa pruriginosa with extensive truncal involvement treated with upadacitinib
- Epidermolysis Bullosa: A Report of Three Cases with Novel Heterozygous Deletions in PLEC and Homozygous Non sense Mutations in COL7A1 Genes
- Epidermolysis Bullosa: Two rare case reports of COL7A1 and EBS-GEN SEV KRT14 variants with review of literature
- Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa
- Extremely mild dominant dystrophic epidermolysis bullosa: Genotype information from whole-exome sequencing of salivary gDNA predicts disease severity
- Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa
- Gene-Modified Blister Fluid-Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa
- Generation and characterization of induced pluripotent stem cell lines from two patients with recessive dystrophic epidermolysis Bullosa
- Generation of a recessive dystrophic epidermolysis bullosa mouse model with patient-derived compound heterozygous mutations
- Generation of the induced pluripotent stem cell line (ZSPHARi001-A) from a patient with recessive dystrophic epidermolysis bullosa carrying compound heterozygous mutation in the COL7A1 gene
- Genes and compounds that increase type VII collagen expression as potential treatments for dystrophic epidermolysis bullosa
- Genotype and phenotype correlations in 441 patients with epidermolysis bullosa from China
- Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa
- Haplotype-based non-invasive prenatal diagnosis of recessive dystrophic epidermolysis bullosa via targeted capture sequencing of maternal plasma
- Hereditary epidermolysis bullosa: clinical-epidemiological profile of 278 patients at a tertiary hospital in Sao Paulo, Brazil
- Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization
- Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa
- Identification of a novel COL7A1 variant associated with dystrophic epidermolysis bullosa pruriginosa responding effectively to dupilumab
- Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
- Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser
- In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin
- In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin
- In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial
- Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB)
- Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
- Interrogation of RDEB Epidermal Allografts after BMT Reveals Coexpression of Collagen VII and Keratin 15 with Proinflammatory Immune Cells and Fibroblasts
- Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial
- Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5(+) Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa
- Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5<sup>+</sup> Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa
- Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa
- Losartan treatment improves recessive dystrophic epidermolysis bullosa: A case series
- Maintenance of chronicity signatures in fibroblasts isolated from recessive dystrophic epidermolysis bullosa chronic wound dressings under culture conditions
- Management of acute sloughing of the esophageal lining in patients with dystrophic epidermolysis bullosa-A series of six pediatric patients
- Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis
- Methods for Decreasing Preweaning Mortality in a Fragile Mouse Model of Hypomorphic Collagen VII Deficiency
- Missense Variant c.3301C>T (p.R1101W) in von Willebrand Factor A Sequence in a Patient with Recessive Dystrophic Epidermolysis Bullosa Pruriginosa with Compound Heterozygous <em>COL7A1</em> Variants
- Missense Variant c.3301C>T (p.R1101W) in von Willebrand Factor A Sequence in a Patient with Recessive Dystrophic Epidermolysis Bullosa Pruriginosa with Compound Heterozygous COL7A1 Variants
- Mutational analysis of epidermolysis bullosa in Taiwan by whole-exome sequencing complemented by RNA sequencing: a series of 77 patients
- New options to manage epidermolysis bullosa
- Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib
- Novel frameshift mutation in the noncollagenous region of the COL7A1 gene in pretibial epidermolysis bullosa
- Novel variants in LAMA3 and COL7A1 and recurrent variant in KRT5 underlying epidermolysis bullosa in five Chinese families
- Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa
- Otological complications in inversa type recessive dystrophic epidermolysis bullosa
- Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study
- Phenotype and genotype correlation of inherited epidermolysis bullosa in Indonesia
- Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa
- Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al
- Restoring type VII collagen in skin
- Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
- Self-improving dystrophic epidermolysis bullosa with a novel heterozygous missense variant in the COL7A1 gene in a Taiwanese family
- Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa
- Successful Control of Recalcitrant Pruritus in Epidermolysis Bullosa Pruriginosa With Dupilumab
- Successful treatment of epidermolysis bullosa pruriginosa by dupilumab
- T-cell activation and bacterial infection in skin wounds of recessive dystrophic epidermolysis bullosa patients
- Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa
- Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa
- Two cases of the intermediate phenotype of recessive dystrophic epidermolysis bullosa harboring the novel COL7A1 mutation c.3570G>A
- Two cases of the intermediate phenotype of recessive dystrophic epidermolysis bullosa harboring the novel COL7A1 mutation c.3570G>A
- Two sisters with recessive dystrophic epidermolysis bullosa caused by novel variants in COL7A1
- Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa
- Variation of COL7A1 gene in dystrophic epidermolysis bullosa pruriginosa
- Whole exome sequencing identified a novel compound heterozygous variation in COL7A1 gene causing dystrophic epidermolysis bullosa
- Whole exome sequencing in a sample of Peruvian patients diagnosed with epidermolysis bullosa